Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 313

DECLARATION re #311 Brief in Support of Proposed Claim Construction by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit A#2 Exhibit B#3 Exhibit C part 1#4 Exhibit C part 2#5 Exhibit D part 1#6 Exhibit D part 2#7 Exhibit E part 1#8 Exhibit E part 2#9 Exhibit F#10 Exhibit G part 1#11 Exhibit G part 2#12 Exhibit H#13 Exhibit I#14 Exhibit J#15 Exhibit K#16 Exhibit L#17 Exhibit M part 1#18 Exhibit M part 2#19 Exhibit N#20 Exhibit O#21 Exhibit P part 1#22 Exhibit P part 2#23 Exhibit Q#24 Exhibit R#25 Exhibit S)(Fleming, Thomas)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 313

Case 1:05-cv-12237-WGY

Document 313

Filed 03/05/2007

Page 1 of 3

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ____________________________________ AMGEN INC., ) ) Plaintiff, ) ) vs. ) ) F. HOFFMANN-LA ROCHE LTD, ) ROCHE DIAGNOSTICS GmbH, and ) HOFFMANN-LA ROCHE INC. ) ) Defendants. ) _________________________________ __)

CIVIL ACTION No.: 05-cv-12237WGY

DECLARATION OF THOMAS F. FLEMING IN SUPPORT OF DEFENDANTS PROPOSED CLAIM CONSTRUCTION Lee Carl Bromberg (BBO# 058480) Julia Huston (BBO# 562160) Keith E. Toms (BBO# 663369) Nicole A. Rizzo (BBO# 663853) BROMBERG & SUNSTEIN LLP 125 Summer Street Boston, MA 02110 Tel. [phone] Leora Ben-Ami (pro hac vice) Mark S. Popofsky (pro hac vice) Patricia A. Carson (pro hac vice) Thomas F. Fleming (pro hac vice) Howard S. Suh (pro hac vice) Peter Fratangelo (BBO# 639775) KAYE SCHOLER LLP 425 Park Avenue New York, New York 10022 Tel. [phone] Counsel for Defendants, F. HOFFMANN-LA ROCHE LTD, ROCHE DIAGNOSTICS GmbH, and HOFFMANN-LA ROCHE INC.
1

Dated: March 5, 2007

31429933.DOC

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 313

Filed 03/05/2007

Page 2 of 3

I, Thomas F. Fleming, hereby declare under penalty of perjury that: 1. I am an attorney admitted to the Bar of the State of New York and am a Partner in the law firm of Kaye Scholer LLP, counsel for Defendants in the above captioned case. 2. I make this reply declaration in further support of Defendants Proposed Claim Construction, dated March 5, 2007. 3. Exhibit A is a true and correct copy of U.S. Patent Nos. 5,441,868. 4. Exhibit B is a true and correct copy of U.S. Patent Nos. 5,547,933. 5. Exhibit C is a true and correct copy of U.S. Patent Nos. 5,618,698. 6. Exhibit D is a true and correct copy of U.S. Patent Nos. 5,621,080. 7. Exhibit E is a true and correct copy of U.S. Patent Nos. 5,756,349. 8. Exhibit F is a true and correct copy of U.S. Patent Nos. 5,955,422. 9. Exhibit G is a true and correct copy of Expert Declaration of Thomas R. Kadesch, Ph.D., Professor of Genetics at the University of Pennsylvania School of Medicine, and attached exhibits. 10. Exhibit H is a true and correct copy of May 5, 1999, Amendment, 08/100,197-33. 11. Exhibit I is a true and correct copy of Goldwasser Depo. Tr. February 14, 2007 12. Exhibit J is a true and correct copy of March 31, 1995, Office Action, '197 FH. 13. Exhibit K is a true and correct copy of February 10, 1989, Office Action, 07/113,178-9
2

31429933.DOC

Case 1:05-cv-12237-WGY

Document 313

Filed 03/05/2007

Page 3 of 3

14. Exhibit L is a true and correct copy of June 2, 1989, Amendment Under Rule 116, 113,178. 15. Exhibit M is a true and correct copy of May 24, 1988, Second Preliminary Amendment, 07/113,179-8. 16. Exhibit N is a true and correct copy of September 1, 1993, Office Action, 07/113,179-29. 17. Exhibit O is a true and correct copy of January 10, 1994, Amendment and Response, 07/113,179-33. 18. Exhibit P is a true and correct copy of Brief for Lin in Interference No. 102,097 19. Exhibit Q is a true and correct copy of U.S. Patent No. 4,399,216. 20. Exhibit R is a true and correct copy of MANUAL OF PATENT EXAMINING PROCEDURE § 2173.05(h) I 21. Exhibit S is a true and correct copy of MANUAL OF PATENT EXAMINING PROCEDURE § 608.01(p) Completeness [R-3]. Dated: March 5, 2007 Respectfully submitted, /s/ Thomas F. Fleming

CERTIFICATE OF SERVICE I hereby certify that this document filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) and paper copies will be sent to those indicated as non registered participants on the above date. /s/ Thomas F. Fleming Thomas F. Fleming
3

31429933.DOC